Akari Therapeutics (AKTX) had the highest return between 2010 and 2014 by a US stock, returning 153,599,900%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Akari Therapeutics (AKTX) | 2010-2014 | 153,599,900% |
Cenntro Electric (CENN) | 2010-2014 | 114,285,614.27% |
Mesoblast (MESO) | 2010-2014 | 35,519,900% |
QXO (QXO) | 2010-2014 | 7,392,225% |
Evogene (EVGN) | 2010-2014 | 3,683,900% |
Avita Medical (RCEL) | 2010-2014 | 1,549,900% |
Travere Therapeutics (TVTX) | 2010-2014 | 1,019,900% |
Nutex Health (NUTX) | 2010-2014 | 399,900.3% |
Prairie Operating Co Common Stock (PROP) | 2010-2014 | 220,488.25% |
Scienture (SCNX) | 2010-2014 | 201,290.58% |
Cementos Pacasmayo SAA ADR (CPAC) | 2010-2014 | 178,735% |
NextTrip (NTRP) | 2010-2014 | 178,566.67% |
Aurinia Pharmaceuticals (AUPH) | 2010-2014 | 110,203.03% |
Supernus Pharmaceuticals (SUPN) | 2010-2014 | 105,831.65% |
Anfield Energy (AEC) | 2010-2014 | 94,836.71% |
BTCS (BTCS) | 2010-2014 | 41,179.49% |
Lipocine (LPCN) | 2010-2014 | 17,784% |
Optex Systems Holdings, Inc Common Stock (OPXS) | 2010-2014 | 10,613.67% |
Eva Live Inc Common Stock (GOAI) | 2010-2014 | 8,899.5% |
Natural Health Trend (NHTC) | 2010-2014 | 8,113.73% |
Xpel (XPEL) | 2010-2014 | 7,931.58% |
Xcel Brands (XELB) | 2010-2014 | 6,863.79% |
Actinium Pharmaceuticals (ATNM) | 2010-2014 | 5,254.54% |
Cocrystal Pharma (COCP) | 2010-2014 | 3,689.28% |
Vipshop (VIPS) | 2010-2014 | 3,156.72% |